Literature DB >> 3037483

Enzymatic amplification of translation inhibition of rabbit beta-globin mRNA mediated by anti-messenger oligodeoxynucleotides covalently linked to intercalating agents.

C Cazenave, N Loreau, N T Thuong, J J Toulmé, C Hélène.   

Abstract

The effects of anti-messenger oligodeoxynucleotides, covalently linked to an intercalating agent, on translation of rabbit beta-globin mRNA, were investigated both in wheat germ extract and in microinjected Xenopus oocytes. A specific inhibition of beta-globin synthesis was observed in both expression systems with a modified 11-mer covalently linked to an acridine derivative. In injected oocytes a more efficient block was observed with this modified oligonucleotide than with its unsubstituted homolog. This was ascribed to stacking interactions of the intercalating agent with base pairs which provide an additional stabilization of the [mRNA/DNA] hybrid. We demonstrated that in wheat germ extract, the modified and unmodified oligonucleotides behaved similarly due to the presence of a high RNaseH activity. RNaseH was also present, although to a lesser extent, in the oocyte cytoplasm. This anti-messenger DNA-induced degradation of target mRNA resulted in amplified efficiency of hybrid-arrested translation. This additional mechanism might provide anti-sense DNAs with an advantage over anti-sense RNAs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037483      PMCID: PMC305914          DOI: 10.1093/nar/15.12.4717

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  57 in total

Review 1.  The role of antisense RNA in gene regulation.

Authors:  P J Green; O Pines; M Inouye
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

2.  Production of phenocopies by Krüppel antisense RNA injection into Drosophila embryos.

Authors:  U B Rosenberg; A Preiss; E Seifert; H Jäckle; D C Knipple
Journal:  Nature       Date:  1985 Feb 21-27       Impact factor: 49.962

3.  Targeted cleavage of polynucleotides by complementary oligonucleotides covalently linked to iron-porphyrins.

Authors:  T Le Doan; L Perrouault; C Helene; M Chassignol; N T Thuong
Journal:  Biochemistry       Date:  1986-11-04       Impact factor: 3.162

4.  Translational control of globin synthesis by haemin in Xenopus oocytes.

Authors:  B Giglioni; A M Gianni; P Comi; S Ottolenghi; D Rungger
Journal:  Nat New Biol       Date:  1973-11-28

5.  A unique mechanism regulating gene expression: translational inhibition by a complementary RNA transcript (micRNA).

Authors:  T Mizuno; M Y Chou; M Inouye
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Discriminatory function of ribonuclease H in the selective initiation of plasmid DNA replication.

Authors:  G Hillenbrand; W L Staudenbauer
Journal:  Nucleic Acids Res       Date:  1982-02-11       Impact factor: 16.971

7.  Translational control of IS10 transposition.

Authors:  R W Simons; N Kleckner
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

8.  Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.

Authors:  P C Zamecnik; M L Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

9.  Stable reduction of thymidine kinase activity in cells expressing high levels of anti-sense RNA.

Authors:  S K Kim; B J Wold
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

10.  Sequence-specific cleavage of single-stranded DNA: oligodeoxynucleotide-EDTA X Fe(II).

Authors:  G B Dreyer; P B Dervan
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

View more
  45 in total

Review 1.  Peptide nucleic acids: versatile tools for gene therapy strategies.

Authors:  D A Dean
Journal:  Adv Drug Deliv Rev       Date:  2000-11-15       Impact factor: 15.470

2.  The experimental use of antisense oligonucleotides: a guide for the perplexed.

Authors:  C A Stein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase H using chimeric methylphosphonodiester/phosphodiester structures.

Authors:  R V Giles; D M Tidd
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

Review 4.  Heterologous expression of calcium channels.

Authors:  J Nargeot; N Dascal; H A Lester
Journal:  J Membr Biol       Date:  1992-03       Impact factor: 1.843

5.  Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism.

Authors:  C Boiziau; R Kurfurst; C Cazenave; V Roig; N T Thuong; J J Toulmé
Journal:  Nucleic Acids Res       Date:  1991-03-11       Impact factor: 16.971

6.  Thermodynamic and kinetic characterization of antisense oligodeoxynucleotide binding to a structured mRNA.

Authors:  S Patrick Walton; Gregory N Stephanopoulos; Martin L Yarmush; Charles M Roth
Journal:  Biophys J       Date:  2002-01       Impact factor: 4.033

7.  Selective inhibition of cell-free translation by oligonucleotides targeted to a mRNA hairpin structure.

Authors:  R Le Tinévez; R K Mishra; J J Toulmé
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

8.  Oligo-[alpha]-deoxynucleotides covalently linked to an intercalating agent. Double helices with parallel strands are formed with complementary oligo-[beta]-deoxynucleotides.

Authors:  J S Sun; U Asseline; D Rouzaud; T Montenay-Garestier; T T Nguyen; C Hélène
Journal:  Nucleic Acids Res       Date:  1987-08-11       Impact factor: 16.971

9.  Triplex-forming oligonucleotides trigger conformation changes of a target hairpin sequence.

Authors:  E Brossalina; E Demchenko; Y Demchenko; V Vlassov; J J Toulmé
Journal:  Nucleic Acids Res       Date:  1996-09-01       Impact factor: 16.971

10.  Predicting antisense oligonucleotide inhibitory efficacy: a computational approach using histograms and thermodynamic indices.

Authors:  R A Stull; L A Taylor; F C Szoka
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.